Company intelligence / Profile preview

Orient Gene

Ownership: Private
Employees: ~2276
Development stage: Commercial

Overview

Orient Gene is a leading Chinese developer and manufacturer of in vitro diagnostic products. The company has achieved international recognition for its rapid point-of-care tests and molecular diagnostics across infectious diseases and other health conditions. Its COVID‑19/Flu/RSV/Adeno antigen combo test kit recently received EU IVDR certification. The company’s products are widely used globally in clinical settings.

Therapeutic areas: OtherWomen's HealthCardiovascularInfectious Diseases
Modalities: Diagnostic reagentPoint of care testing (POCT)Molecular diagnosis
Industry: Molecular Diagnostics

Partnerships

Bill & Melinda Gates FoundationZhejiang University

Beyond the preview

Go deeper on Orient Gene.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orient Gene.

Explore the full profile